Hair dye use and the risk of developing systemic lupus erythematosus a cohort study

Arthritis and Rheumatism

Volumn 39, Issue 4, 1996, Pages 657-662

  Sanchez Guerrero, Jorge ^a   Karlson, Elizabeth W ^a   Colditz, Graham A ^a,b   Hunter, David J ^a   Speizer, Frank E ^a   Liang, Matthew H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b CHANNING LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HAIR DYE;

ADULT; ARTICLE; DISEASE CLASSIFICATION; DOSE TIME EFFECT RELATION; FEMALE; FREQUENCY ANALYSIS; HAIR COLOR; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; INCIDENCE; NORMAL HUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SELF REPORT; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HAIR DYES; HUMANS; INCIDENCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 0029869634     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780390418     Document Type: Article

References (25)

1. Steinberg AD, Gourley MF, Klinman DM, Tsokos GC, Scott DE, Krieg AM: Systemic lupus erythematosus. NIH conference. Ann Intern Med 115:548-559, 1991
2. Fritzler MJ, Rubin RL: Drug-induced lupus. In, Dubois' Lupus Erythematosus. Fourth edition. Edited by DJ Wallace, BH Hahn. Philadelphia, Lea & Febiger, 1993
3. Reidenberg MM: Aromatic amines and the pathogenesis of lupus erythematosus. Am J Med 75:1037-1042, 1983
4. Reidenberg MM, Durant PJ, Harris RA, De Boccardo G, Lahita R. Stenzel KH: Lupus erythematosus-like disease due to hydrazine. Am J Med 75:365-370, 1983
5. Toth B: Synthetic and naturally occurring hydrazines as possible cancer causative agents. Cancer Res 35:3693-3697, 1975
6. Ames BN, Kammen HO, Yamasaki E: Hair dyes are mutagenic: identification of a variety of mutagenic ingredients. Proc Nat Acad Sci U S A 72:2423-2427, 1975
7. Freni-Titulaer LWJ, Kelley DB, Grow AG, McKinley TW, Arnett FC, Hochberg MC: Connective tissue disease in southeastern Georgia: a case-control study of etiologic factors. Am J Epidemiol 130:404-409, 1989
8. Brown K, Petri M, Goldman D: Cutaneous manifestations of SLE: associations with other manifestations of SLE and with smoking (abstract). Arthritis Rheum 38 (suppl 6):R27, 1995
9. Petri M, Allbritton J: Hair product use in systemic lupus erythematosus: a case-control study. Arthritis Rheum 35:625-629, 1992
10. Reidenberg MM, Drayer DE, Lorenzo B, Strom BL, West SL, Snyder ES, Freundlich B, Stolley PD: Acetylation phenotypes and environmental chemical exposure of people with idiopathic systemic lupus erythematosus. Arthritis Rheum 36:971-973, 1993
11. Grodstein F, Hennekens CH, Colditz GA, Hunter DJ, Stampfer MJ: A prospective study of permanent hair dye use and hematopoietic cancer. J Natl Cancer Inst 86:1466-1470, 1994
12. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324, 1988
13. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277, 1982
14. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581-590, 1980
15. Alarcon-Segovia D, Cardiel MH: Comparison between 3 diagnostic criteria for mixed connective tissue disease: study of 593 patients. J Rheumatol 16:328-334, 1989
16. Bohan A, Peter JB, Bowman RL, Pearson CM: A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 56:255-286, 1977
17. Fox RI, Robinson C, Curd J, Kozin F, Howell FV: First international symposium on Sjögren's syndrome: suggested criteria for classification. Scand J Rheumatol Suppl 61:28-30, 1986
18. Karlson EW, Sanchez-Guerrero J, Wright EA, Lew RA, Daltroy LH, Katz JN, Liang MH: A connective tissue disease screening questionnaire for population studies. Ann Epidemiol 5:297-302, 1995
19. Rothman KJ, Boice JD: Epidemiologic Analysis with a Programmable Calculator. Washington, DC, Public Health Service, 1979 (NIH publication no. 79-1649)
20. Colditz GA, Martin P, Stampfer MJ, Willett WC, Sampson L, Rosner B, Hennekens CH, Speizer FH: Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol 123:894-900, 1986
21. Shore RE, Pasternack BS, Thiessen EU, Shadow M, Forbes R, Albert RE: A case-control study of hair dye use and breast cancer. J Natl Cancer Inst 62:277-283, 1979
22. Michet CJ Jr, McKenna CH, Elveback LR, Kaslow RA, Kurland LT: Epidemiology of SLE and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 60:105-113, 1985
23. Hochberg MC: The incidence of systemic lupus erythematosus in Baltimore, Maryland, 1970-1977. Arthritis Rheum 28:80-86, 1985
24. Nived O, Sturfelt G, Wollheim F: Systemic lupus erythematosus in an adult population in southern Sweden: incidence, prevalence and validity of ARA revised classification criteria. Br J Rheumatol 24:147-154, 1985
25. Siegel M, Lee SL: The epidemiology of systemic lupus erythematosus. Semin Arthritis Rheum 3:1-54, 1973